Plain-English translation of NCT06718569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study aims to better understand chronic pain in people with inflammatory arthritis—including rheumatoid arthritis, psoriatic arthritis, and other related conditions. Researchers want to learn why pain affects people differently and how starting or switching to biological or targeted synthetic medications impacts pain levels and disease activity. You would participate in a long-term study that tracks your pain, symptoms, and how well the medication works for you.
Many people with inflammatory arthritis continue to experience significant pain even after starting treatment with newer medications. This study exists to identify different pain patterns and understand what factors—including how the nervous system processes pain and cognitive factors—influence who benefits most from these treatments, so doctors can eventually offer more personalized pain management.
You likely qualify if…
You likely don't qualify if…
As a participant, you would enroll when you start or switch to a new biologic or targeted medication for your arthritis. Over the course of the study, you would complete questionnaires and assessments about your pain levels, joint symptoms, cognitive functioning, and how well the medication is working. The research team will follow you over time to see how your pain and disease activity change as you take the medication.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Norway
Collaborators
University of Oslo
Enrollment target
~350 participants
Started
November 2025
Primary completion
November 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ida K Haugen, MD PhD
Diakonhjemmet Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.